SCHEMBL3850113

SCHEMBL3850113

Fc1ccc(-c2nn(C(c3ccccc3)(c3ccccc3)c3ccccc3)cc2-c2cc(Cl)c3nccn3c2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.38
SRC P12931 2/20 0.37
BRAF P15056 2/20 0.37
KDR P35968 2/20 0.37
NPC1 O15118 2/20 0.36
NFKB1 P19838 2/20 0.36
RAB9A P51151 2/20 0.36
NFKB2 Q00653 2/20 0.36
RELA Q04206 2/20 0.36
LMNA P02545 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
RECQL P46063 1/20 0.36
CDK1 P06493 1/20 0.35
CDK4 P11802 1/20 0.35
CCNB1 P14635 1/20 0.35
CCNA2 P20248 1/20 0.35
CCND1 P24385 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3849827 0.90 TGFBR1 (0.39) SMN1; SMN2NPC1NFKB1RAB9ANFKB2
SCHEMBL3849569 0.90 CDK1 (0.36) SMN1; SMN2SRCBRAFKDRNPC1
SCHEMBL3846676 0.88 ADORA2A (0.36) SRCBRAFKDRNPC1NFKB1
SCHEMBL3845543 0.82 TGFBR1 (0.47) SRCBRAFKDRCYP1A2TGFBR1
SCHEMBL3850115 0.82 SMN1; SMN2 (0.32) SMN1; SMN2SRCBRAFKDRNPC1
SCHEMBL3846334 0.80 SMN1; SMN2 (0.39) SMN1; SMN2SRCBRAFKDRNPC1
SCHEMBL3847277 0.79 SMN1; SMN2 (0.36) SMN1; SMN2SRCBRAFKDRNPC1
SCHEMBL3846052 0.77 KDR (0.37) SMN1; SMN2SRCBRAFKDRCSNK1D
SCHEMBL3846702 0.76 RORC (0.39) CSNK1DCSNK1EMAPK13MAPK12MAPK11
SCHEMBL3847999 0.74 KCNN4 (0.38) SMN1; SMN2NPC1NFKB1RAB9ANFKB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed